Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural Networks
Open Access
- 1 September 2015
- Vol. 17 (9) , 704-715
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research UK Glasgow Centre
- Glasgow Experimental Cancer Medicine Centre
- Cancer Research UK
- Chief Scientist Office, Scotland
- Cancer Research UK
- University of Cambridge
- Cancer Research UK Cambridge Institute Core Grant
- Hutchison Whampoa
This publication has 50 references indexed in Scilit:
- A high-content cellular senescence screen identifies candidate tumor suppressors, including EPHA3Cell Cycle, 2013
- TDT-HET: A new transmission disequilibrium test that incorporates locus heterogeneity into the analysis of family-based association dataBMC Bioinformatics, 2012
- Discovery of 2‐(2‐Benzoxazoyl amino)‐4‐Aryl‐5‐Cyanopyrimidine as Negative Allosteric Modulators (NAMs) of Metabotropic Glutamate Receptor 5 (mGlu5): From an Artificial Neural Network Virtual Screen to an In Vivo Tool CompoundChemMedChem, 2012
- An RNA interference screen for identifying downstream effectors of the p53 and pRB tumour suppressor pathways involved in senescenceBMC Genomics, 2011
- Software and Resources for Computational Medicinal ChemistryFuture Medicinal Chemistry, 2011
- Therapy-Induced Senescence in CancerJNCI: Journal of the National Cancer Institute, 2010
- Scoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage in peritoneal mesotheliomaBMC Genomics, 2010
- An overview of the PubChem BioAssay resourceNucleic Acids Research, 2009
- Dynamic Telomerase Gene Suppression via Network Effects of GSK3 InhibitionPLOS ONE, 2009
- PowerMV: A Software Environment for Molecular Viewing, Descriptor Generation, Data Analysis and Hit EvaluationJournal of Chemical Information and Modeling, 2005